An enhanced expression of a number of IAPs, including cIAP1, IAP2, survivin, XIAP in colorectal tumors has been correlated with worse survival, disease recurrence, and liver metastasis, which defines poorer prognosis [59]. This evidence concerns the gene BIRC5 and colorectal neoplasm.